{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:33:21Z","timestamp":1791344001041,"version":"4.3.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2006,2,16]],"date-time":"2006-02-16T00:00:00Z","timestamp":1140048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,16]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Multiple myeloma (MM) is a B cell cancer characterized by clonal proliferation in the bone marrow and impaired immunity. Because MM is an incurable malignancy, efficient consolidation is needed urgently. Targeting clonotypic B cells by idiotype vaccination has proved the principle to be effective and indicated that future strategies, including dendritic cell-based vaccination, could be a suitable approach. However, as MM patients suffer from a general impaired immunity, which may include dendritic cells (DCs), a careful evaluation of phenotypic traits and functionality of DCs from MM patients is necessary before an efficient vaccine can be developed. This study determined the number, phenotypic profile and functionality of myeloid and plasmacytoid DCs purified directly from blood from MM patients at diagnosis. A reduced number and lower expression of human leucocyte antigen (HLA) molecules was observed on both myeloid and plasmacytoid DCs in MM patients compared to healthy controls. Also, the expression of CCR5, CCR7 and DEC205 was lower in MM patients compared to normal donors. In addition, the capacity to stimulate allogeneic T cell proliferation and to stimulate cytokine production was decreased, suggesting that DCs from these patients are functionally impaired. Finally, the analysis of samples following chemotherapy and transplantation demonstrated an increased expression of HLA molecules, suggesting that this time-point is optimal for harvest and use in vaccination.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2006.03037.x","type":"journal-article","created":{"date-parts":[[2006,2,23]],"date-time":"2006-02-23T15:49:15Z","timestamp":1140709755000},"page":"76-84","source":"Crossref","is-referenced-by-count":83,"title":["Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma"],"prefix":"10.1093","volume":"144","author":[{"given":"M K","family":"Brimnes","sequence":"first","affiliation":[{"name":"Departments of Haematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I M","family":"Svane","sequence":"additional","affiliation":[{"name":"Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H E","family":"Johnsen","sequence":"additional","affiliation":[{"name":"Departments of Haematology"},{"name":"Department of Haematology, Aalborg Hospital, University of Aarhus, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,2,23]]},"reference":[{"key":"2022010518592279300_b1","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1200\/JCO.2000.18.16.3031","article-title":"Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome","volume":"18","author":"Lokhorst","year":"2000","journal-title":"J Clin Oncol"},{"key":"2022010518592279300_b2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood.V96.1.355","article-title":"Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma","volume":"96","author":"Cavo","year":"2000","journal-title":"Blood"},{"issue":"Suppl. 1","key":"2022010518592279300_b3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/10245330512331389953","article-title":"Current issues in allogeneic stem cell transplantation","volume":"10","author":"Socie","year":"2005","journal-title":"Hematology"},{"key":"2022010518592279300_b4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"2022010518592279300_b5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"2022010518592279300_b6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1081\/CNV-120025091","article-title":"The first 1000 dendritic cell vaccinees","volume":"21","author":"Ridgway","year":"2003","journal-title":"Cancer Invest"},{"key":"2022010518592279300_b7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J Exp Med"},{"key":"2022010518592279300_b8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V100.1.174","article-title":"Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans","volume":"100","author":"Dhodapkar","year":"2002","journal-title":"Blood"},{"key":"2022010518592279300_b9","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance","volume":"196","author":"Bonifaz","year":"2002","journal-title":"J Exp Med"},{"key":"2022010518592279300_b10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2022010518592279300_b11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0163-7258(93)90021-5","article-title":"Human natural interferon-alpha producing cells","volume":"60","author":"Fitzgerald-Bocarsly","year":"1993","journal-title":"Pharmacol Ther"},{"key":"2022010518592279300_b12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/JVI.79.1.17-27.2005","article-title":"Plasmacytoid dendritic cells: linking innate and adaptive immunity","volume":"79","author":"McKenna","year":"2005","journal-title":"J Virol"},{"key":"2022010518592279300_b13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20040035","article-title":"Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen","volume":"200","author":"De Heer","year":"2004","journal-title":"J Exp Med"},{"key":"2022010518592279300_b14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V100.1.230","article-title":"Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6","volume":"100","author":"Ratta","year":"2002","journal-title":"Blood"},{"key":"2022010518592279300_b15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/14653240410006004","article-title":"Impaired circulating myeloid DCs from myeloma patients","volume":"6","author":"Do","year":"2004","journal-title":"Cytotherapy"},{"key":"2022010518592279300_b16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2141.2004.04984.x","article-title":"Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma","volume":"125","author":"Brown","year":"2004","journal-title":"Br J Haematol"},{"key":"2022010518592279300_b17","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood.V98.10.2992","article-title":"Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10","volume":"98","author":"Brown","year":"2001","journal-title":"Blood"},{"key":"2022010518592279300_b18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood.V93.5.1487","article-title":"Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi\u2019s sarcoma herpesvirus gene sequences","volume":"93","author":"Raje","year":"1999","journal-title":"Blood"},{"key":"2022010518592279300_b19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s002810000053","article-title":"Dendritic cell biology and regulation of dendritic cell trafficking by chemokines","volume":"22","author":"Caux","year":"2000","journal-title":"Springer Semin Immunopathol"},{"key":"2022010518592279300_b20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/375151a0","article-title":"The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing","volume":"375","author":"Jiang","year":"1995","journal-title":"Nature"},{"key":"2022010518592279300_b21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1083\/jcb.151.3.673","article-title":"The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments","volume":"151","author":"Mahnke","year":"2000","journal-title":"J Cell Biol"},{"key":"2022010518592279300_b22","first-page":"4497","article-title":"The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response","volume":"63","author":"Orsini","year":"2003","journal-title":"Cancer Res"},{"key":"2022010518592279300_b23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2141.2004.04971.x","article-title":"Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitro","volume":"125","author":"Orsini","year":"2004","journal-title":"Br J Haematol"},{"key":"2022010518592279300_b24","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.leu.2403474","article-title":"Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate","volume":"18","author":"Boissel","year":"2004","journal-title":"Leukemia"},{"key":"2022010518592279300_b25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.0007-1048.2001.03318.x","article-title":"Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia","volume":"116","author":"Bourguin-Plonquet","year":"2002","journal-title":"Br J Haematol"},{"key":"2022010518592279300_b26","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood.V98.13.3750","article-title":"Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment","volume":"98","author":"Mohty","year":"2001","journal-title":"Blood"},{"key":"2022010518592279300_b27","first-page":"1755","article-title":"Clinical significance of defective dendritic cell differentiation in cancer","volume":"6","author":"Almand","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2022010518592279300_b28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/sj.bjc.6601243","article-title":"Altered maturation of peripheral blood dendritic cells in patients with breast cancer","volume":"89","author":"Della","year":"2003","journal-title":"Br J Cancer"},{"key":"2022010518592279300_b29","first-page":"483","article-title":"Decreased antigen presentation by dendritic cells in patients with breast cancer","volume":"3","author":"Gabrilovich","year":"1997","journal-title":"Clin Cancer Res"},{"key":"2022010518592279300_b30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00262-003-0485-5","article-title":"Dendritic cells are dysfunctional in patients with operable breast cancer","volume":"53","author":"Satthaporn","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"2022010518592279300_b31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1365-2141.2001.03223.x","article-title":"Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia","volume":"115","author":"Vuillier","year":"2001","journal-title":"Br J Haematol"},{"key":"2022010518592279300_b32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2141.2001.03117.x","article-title":"Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern","volume":"115","author":"Rezvany","year":"2001","journal-title":"Br J Haematol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2006.03037.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/144\/1\/76\/42073988\/j.1365-2249.2006.03037.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/144\/1\/76\/42073988\/j.1365-2249.2006.03037.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T19:01:16Z","timestamp":1641409276000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/144\/1\/76\/6457230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,2,23]]},"published-print":{"date-parts":[[2006,2,16]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03037.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,4]]},"published":{"date-parts":[[2006,2,16]]}}}